UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 362

Sortiert nach

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Gut, 2006-03, Vol.55 (3), p.403-408

2006

Volltextzugriff (PDF)

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

Journal of viral hepatitis, 2012-04, Vol.19 (4), p.244-253

2012

Volltextzugriff (PDF)

P203 Fibrose hépatique chez les patients diabétiques : rôles de la stéatose et de l’accumulation de produits de glycation avancée

Diabetes & metabolism, 2014-03, Vol.40, p.A76-A76

2014

Volltextzugriff (PDF)

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

Alimentary pharmacology & therapeutics, 2007-03, Vol.25 (6), p.733-739

2007

Volltextzugriff (PDF)

78 VALIDATION OF CONTROLLED ATTENUATION PARAMETER (CAP) AS A NON-INVASIVE MARKER OF STEATOSIS IN 228 PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSES

Journal of hepatology, 2010, Vol.52, p.S35-S36

2010

Volltextzugriff (PDF)

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

Alimentary pharmacology & therapeutics, 2017-09, Vol.46 (6), p.617-627

2017

Volltextzugriff (PDF)

989 NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI ≥ 30 kg/m2

Journal of hepatology, 2009-04, Vol.50, p.S359-S359

2009

Volltextzugriff (PDF)

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

Journal of viral hepatitis, 2007-07, Vol.14 (7), p.460-467

2007

Volltextzugriff (PDF)

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

Alimentary pharmacology & therapeutics, 2017-12, Vol.46 (11-12), p.1054-1060

2017

Volltextzugriff (PDF)

P14 - Les conseils diététiques ont davantage d’effets chez les femmes atteintes de NASH (Non Alcoholic Steato Hepatitis)

Diabetes & metabolism, 2011, Vol.37 (1), p.A39-A39

2011

Volltextzugriff (PDF)

P111 Autofluorescence cutanée chez les patients cirrhotiques

Diabetes & metabolism, 2010, Vol.36, p.A65-A65

2010

Volltextzugriff (PDF)

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

Journal of hepatology, 2015-04, Vol.62, p.S247-S248

2015

Volltextzugriff (PDF)

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Journal of hepatology, 2015-04, Vol.62, p.S213-S214

2015

Volltextzugriff (PDF)

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (10), p.979-988

2013

Volltextzugriff (PDF)

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Clinical chemistry (Baltimore, Md.), 2007-09, Vol.53 (9), p.1615-1622

2007

Volltextzugriff (PDF)

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (7), p.991-1003

2017

Volltextzugriff (PDF)

Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab

Alimentary pharmacology & therapeutics, 2011-03, Vol.33 (6), p.714-721

2011

Volltextzugriff (PDF)

FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study

Journal of viral hepatitis, 2009-02, Vol.16 (2), p.121-131

2009

Volltextzugriff (PDF)

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers

Alimentary pharmacology & therapeutics, 2011-02, Vol.33 (4), p.455-465

2011

Volltextzugriff (PDF)

Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.462-469

2011

Volltextzugriff (PDF)

Diagnostic non invasif de cirrhose dans la « non-alcoholic fatty liver disease » (NAFLD)

Revue d'épidémiologie et de santé publique, 2020-09, Vol.68, p.S130-S130

2020

Volltextzugriff (PDF)

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Journal of hepatology, 2017, Vol.66 (1), p.S669-S670

2017

Volltextzugriff (PDF)

Sexual quality of life is impaired in patients with chronic hepatitis C

International journal of impotence research, 2016-03, Vol.28 (2), p.68-73

2016

Volltextzugriff (PDF)

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

Journal of hepatology, 2016, Vol.64 (2), p.S736-S737

2016

Volltextzugriff (PDF)

Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 Infection

Journal of hepatology, 2017, Vol.66 (1), p.S299-S300

2017

Volltextzugriff (PDF)

1 – 25 von 362

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(335)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(113)
Life Sciences & Biomedicine
(107)
Science & Technology
(107)
Gastroenterology And Hepatology
(94)
Male
(83)
Female
(78)
Gastroenterology & Hepatology
(78)
Middle Aged
(74)
Adult
(71)
Life Sciences
(51)
Biological And Medical Sciences
(50)
Medical Sciences
(49)
Aged
(42)
Gastroenterology. Liver. Pancreas. Abdomen
(32)
Infectious Diseases
(31)
Hepatitis C Virus
(26)
Prospective Studies
(26)
Hepatitis C
(25)
Liver Cirrhosis - Diagnosis
(25)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C

P203 Fibrose hépatique chez les patients diabétiques : rôles de la stéatose et de l’accumulation de produits de glycation avancée

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

78 VALIDATION OF CONTROLLED ATTENUATION PARAMETER (CAP) AS A NON-INVASIVE MARKER OF STEATOSIS IN 228 PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSES

Serial combination of non‐invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD

989 NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI ≥ 30 kg/m2

Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection

The negative impact of HBV/HCV coinfection on cirrhosis and its consequences

P14 - Les conseils diététiques ont davantage d’effets chez les femmes atteintes de NASH (Non Alcoholic Steato Hepatitis)

P111 Autofluorescence cutanée chez les patients cirrhotiques

O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study

G08 : Incidence of hepatocellular carcinoma (HCC) and complications in alcoholic compensated cirrhosis. Preliminary results of a multicenter prospective French and belgian cohort (INCA Cirral)

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Mucosal healing with methotrexate in Crohn’s disease: a prospective comparative study with azathioprine and infliximab

FibroScan used in street-based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers

Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study

Diagnostic non invasif de cirrhose dans la « non-alcoholic fatty liver disease » (NAFLD)

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Sexual quality of life is impaired in patients with chronic hepatitis C

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

Efficacy and safety of sofosbuvir and daclatasvir for 8 weeks in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus Genotype 3 Infection

Suchergebnisse filtern